Evidence map›Paper›PMID 28403186›Full record

ArticlePloS one2017

Binding of interferon reduces the force of unfolding for interferon receptor 1.

Silvia G Chuartzman, Reinat Nevo, Sharon Waichman, Dalit Shental, Jacob Piehler, Yaakov Levy, Ziv Reich, Ruti Kapon

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Silvia G ChuartzmanDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Reinat NevoDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Sharon WaichmanDepartment of Biology, University of Osnabrück, Osnabrück, Germany.
Dalit ShentalDepartment of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Jacob PiehlerDepartment of Biology, University of Osnabrück, Osnabrück, Germany.
Yaakov LevyDepartment of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Ziv ReichDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Ruti KaponDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-0618-6470
Weizmann Institute of Science · ILOsnabrück University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differential signaling of the type I interferon receptor (IFNAR) has been correlated with the ability of its subunit, IFNAR1, to differentially recognize a large spectrum of different ligands, which involves intricate conformational re-arrangements of multiple interacting domains. To shed light onto the structural determinants governing ligand recognition, we compared the force-induced unfolding of the IFNAR1 ectodomain when bound to interferon and when free, using the atomic force microscope and steered molecular dynamics simulations. Unexpectedly, we find that IFNAR1 is easier to mechanically unfold when bound to interferon than when free. Analysis of the structures indicated that the origin of the reduction in unfolding forces is a conformational change in IFNAR1 induced by ligand binding.

Indexed as

HumansInterferon Type IMicroscopy, Atomic ForceMolecular Dynamics SimulationProtein BindingProtein Interaction Domains and MotifsProtein UnfoldingReceptor, Interferon alpha-betaThermodynamicsInterferon Type IReceptor, Interferon alpha-beta

Identifiers

PMID28403186
PMCPMC5389645
OpenAlexW2606470176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.